Radiation or watchful waiting after chemo for seminoma
Part of Cancer clinical trials.
This study compares giving radiation versus observation (no immediate radiation) for men with advanced seminoma whose PET-CT scan shows a leftover mass after first-line chemotherapy. It aims to see which approach controls the disease better while protecting quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of classical seminoma (not another type of testicular/sex-gland tumor).
- Your cancer started in the testis, mediastinum, or retroperitoneum (back of the abdomen).
- Your stage is IIB, IIC, or III after staging.
- You are over 18 years old and can do normal daily activities fairly well (Karnofsky score 70 or higher).
- You finished your planned first chemotherapy treatment, and a PET-CT scan at least 12 weeks later still shows a measurable leftover mass.
- You are able and willing to return for follow-up visits and are okay with being assessed for quality of life.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a less intensive treatment can be used for testicular seminoma that has spread to nearby lymph nodes but is still small (under 3 cm). It aims to keep the cure rate high while reducing side effects.
This study tests if proton beam therapy, a precise type of radiation, is safe and effective for men with early-stage testicular seminoma that has spread to abdominal lymph nodes. It aims to reduce side effects compared to standard radiation while keeping the cancer controlled.
This trial tests lowering the intensity of treatment (de-escalation) for Stage II seminoma, a type of testicular cancer. You may receive either a surgery to remove lymph nodes or a single round of chemotherapy (carboplatin), instead of more aggressive standard treatments, to see if it's safe and effective.
This trial is testing whether removing affected lymph nodes with surgery (RPLND) works well alone for seminoma testicular cancer that has spread to nearby nodes but is still relatively small. It is for patients who have not had extensive chemo or radiation.
This study compares two standard treatments—surgery to remove lymph nodes in the abdomen (RPLND) versus chemotherapy—for men with testicular cancer that has spread to a small area in the abdomen. The goal is to see which approach works better and has fewer side effects.
This study looks at how people with testicular cancer are doing after finishing treatment. It mainly focuses on follow-up visits (surveillance) and whether you are in remission, which can help doctors understand and improve post-treatment care.
Hear when a new Seminoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.